down arrow

Sun Pharma.Inds.

Part of MojoOne Strategy
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE044A01036
  • NSEID: SUNPHARMA
  • BSEID: 524715
  • View on NSE | View on BSE
INR
1,990.50
-10.6 (-0.53%)
BSENSE

Jul 31, 03:30 PM

BSE+NSE Vol: 51.06 lacs

Access older stock analysis version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
15,299.88
14,611.79
15,520.54
14,478.31
13,851.40
12,958.84
13,675.46
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
15,299.88
14,611.79
15,520.54
14,478.31
13,851.40
12,958.84
13,675.46
Raw Material Cost
2,026.28
2,182.44
1,813.48
1,621.51
1,771.59
1,845.06
1,408.31
Purchase of Finished goods
1,019.50
753.34
922.42
1,087.79
1,047.98
1,036.73
1,238.69
(Increase) / Decrease In Stocks
-82.62
-134.69
209.20
273.43
-4.81
-244.60
93.54
Employee Cost
3,227.23
2,960.41
2,892.00
2,764.79
2,801.66
2,488.52
2,552.28
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
4,691.82
4,896.09
4,734.95
4,203.74
3,933.32
4,117.04
4,373.62
Total Expenditure (Excl Depreciation)
10,882.21
10,657.59
10,572.05
9,951.26
9,549.74
9,242.75
9,666.44
Operating Profit (PBDIT) excl Other Income
4,417.67
3,954.20
4,948.49
4,527.05
4,301.66
3,716.09
4,009.02
Other Income
723.62
458.50
578.84
469.92
464.46
612.87
465.62
Operating Profit (PBDIT)
5,141.29
4,412.70
5,527.33
4,996.97
4,766.12
4,328.96
4,474.64
Interest
99.67
85.89
78.36
99.86
74.80
49.14
51.51
Exceptional Items
-204.09
0.00
-489.48
0.00
-818.00
-361.68
-316.17
Gross Profit (PBDT)
4,837.53
4,326.81
4,959.49
4,897.11
3,873.32
3,918.14
4,106.96
Depreciation
738.72
775.47
732.33
729.50
700.55
663.79
630.56
Profit Before Tax
4,098.81
3,551.34
4,227.16
4,167.61
3,172.77
3,254.35
3,476.40
Tax
1,188.01
827.62
826.07
1,030.52
870.15
1,093.71
558.86
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
2,910.80
2,723.72
3,401.09
3,137.09
2,302.62
2,160.64
2,917.54
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
2,910.80
2,723.72
3,401.09
3,137.09
2,302.62
2,160.64
2,917.54
Share in Profit of Associates
-9.57
-14.06
-19.92
-12.14
-9.75
-6.71
-4.56
Minority Interest
6.44
-4.37
12.36
7.00
14.24
4.05
9.60
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
2,894.79
2,714.03
3,368.81
3,117.95
2,278.63
2,149.88
2,903.38
Equity Capital
239.93
239.93
239.93
239.93
239.93
239.93
239.93
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
12.07
11.31
14.04
13.0
9.5
8.96
12.1
Diluted Earnings per share
12.1
11.3
14.0
13.0
9.5
9.0
12.1
Operating Profit Margin (Excl OI)
29.1%
27.16%
31.99%
31.43%
31.2%
29.0%
29.84%
Gross Profit Margin
31.86%
29.72%
32.06%
34.0%
28.1%
30.57%
30.56%
PAT Margin
19.17%
18.71%
21.99%
21.78%
16.7%
16.86%
21.71%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is 4.71% vs -5.86% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is 6.66% vs -19.44% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 11.72% vs -20.09% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is 16.04% vs 9.61% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of Sun Pharma.Inds. With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
15,299.88
2,831.00
12,468.88
440.44%
Other Operating Income
0.00
0.00
0.00
Total Operating income
15,299.88
2,831.00
12,468.88
440.44%
Raw Material Cost
2,026.28
1,214.00
812.28
66.91%
Purchase of Finished goods
1,019.50
0.00
1,019.50
(Increase) / Decrease In Stocks
-82.62
-95.00
12.38
13.03%
Employee Cost
3,227.23
381.00
2,846.23
747.04%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
4,691.82
397.00
4,294.82
1,081.82%
Total Expenditure (Excl Depreciation)
10,882.21
1,897.00
8,985.21
473.65%
Operating Profit (PBDIT) excl Other Income
4,417.67
934.00
3,483.67
372.98%
Other Income
723.62
155.00
568.62
366.85%
Operating Profit (PBDIT)
5,141.29
1,089.00
4,052.29
372.11%
Interest
99.67
6.00
93.67
1,561.17%
Exceptional Items
-204.09
0.00
-204.09
Gross Profit (PBDT)
4,837.53
1,083.00
3,754.53
346.68%
Depreciation
738.72
120.00
618.72
515.60%
Profit Before Tax
4,098.81
963.00
3,135.81
325.63%
Tax
1,188.01
212.00
976.01
460.38%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
2,910.80
751.00
2,159.80
287.59%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
2,910.80
751.00
2,159.80
287.59%
Share in Profit of Associates
-9.57
0.00
-9.57
Minority Interest
6.44
0.00
6.44
Other related items
0.00
0.00
0.00
Consolidated Net Profit
2,894.79
751.00
2,143.79
285.46%
Equity Capital
239.93
53.00
186.93
352.70%
Face Value
1.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
12.07
28.34
-16.27
-57.41%
Diluted Earnings per share
12.10
28.31
-16.21
-57.26%
Operating Profit Margin (Excl OI)
29.10%
32.99%
0.00
-3.89%
Gross Profit Margin
31.86%
38.26%
0.00
-6.40%
PAT Margin
19.17%
26.53%
0.00
-7.36%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 15,299.88 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 4.71% vs -5.86% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 10.46% vs 9.47% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 2,894.79 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 6.66% vs -19.44% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 27.04% vs -19.64% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4,417.67 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 11.72% vs -20.09% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 2.70% vs 19.24% in Jun 2025

Quarterly - Interest
Interest 99.67 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 16.04% vs 9.61% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 33.25% vs 21.55% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 29.10%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Download on App Store
Get it on Google Play
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."